HOME >> MEDICINE >> NEWS
Worsening anemia signals poorer outcomes in men treated for advanced prostate cancer

PORTLAND, Ore. -- Researchers from the Oregon Health & Science University Cancer Institute and Southwest Oncology Group have identified a new method of determining how men with advanced prostate cancer will respond to treatment. They found that worsening anemia during the first three months of hormonal therapy for prostate cancer that has spread predicts shorter survival and earlier relapse.

"These results suggest that by monitoring anemia during the first three months of treatment, we can provide men with a better idea of how well they will fare," said principal investigator Tomasz Beer, M.D., director of the prostate cancer research program in the OHSU Cancer Institute. Beer will present results of this study at the 101st Annual Meeting of the American Urological Association in Atlanta on Tues., May 23.

Researchers also found that race alone was not a strong predictor of survival or disease progression. However, they found that men with the same hemoglobin levels before treatment experienced significantly different overall and progression-free survival depending on whether they were black or white. Hemoglobin levels in the blood are measured to monitor anemia. Lower levels of hemoglobin are considered anemic.

"Outcomes for prostate cancer have always been worse for black men than their white counterparts and the reasons behind this have not been fully understood," Beer said. "Differences in anemia could help us understand why blacks do worse and maybe make it possible to do something about it."

Overall, researchers found that anemic blacks fare worse than anemic whites and that blacks with high baseline hemoglobin fare better than whites with similar hemoglobin levels.

"Our study was not designed to answer questions about this complex and novel finding, but we are examining a number of hypotheses," Beer said.

Anemia is common among newly diagnosed prostate cancer patients with metastatic disease
'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503-494-8231
Oregon Health & Science University
23-May-2006


Page: 1 2 3

Related medicine news :

1. Researchers urge caution in using ESAs for cancer-related anemia
2. Mortality rate increases for kidney recipients with anemia
3. Exercise helps breast cancer patients avoid anemia
4. How bad is malaria anemia? It may depend on your genes
5. Immune culprit in malaria-associated anemia
6. New drug poised to radically change the treatment of severe anemias
7. Hepatitis C drug proves cost-effective in helping patients with treatment-induced anemia
8. Oral liquid hydroxyurea promising for long-term use in babies with sickle cell anemia
9. Study examines effectiveness of anti-anemia drug in treatment of cancer patients
10. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
11. Targeted cancer drugs may work by disrupting balance of cellular signals

Post Your Comments:
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the healthcare ... will lead a discussion about the Internet of Things ... authentication challenges, during Citrix Synergy (May 12-14, ... the benefits of creating a network of IP-connected computers, ... can share information. It will also emphasize the importance ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair ... will now conduct their cooling services, including air conditioning ... commercial and residential units. Strata complex air conditioning services ... technical knowledge as well as a professionally trained staff. ... take away any old air conditioning unit to be ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Baptist ... are the first in north Florida and southeast ... is the latest innovation in total hip replacement ... advanced, surgeon-controlled robotic arm that enables the accurate ... Center Jacksonville has offered MAKOplasty® partial knee resurfacing ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Is Colorado’s ... , Next month the Centennial State will mark the ... cannabis sales to adults. And while Colorado’s legal marijuana ... during that time, it’s also facing some new challenges. ... are currently facing shortages, especially in the wake of ...
(Date:5/6/2015)... Vancouver Chiropractic Clinic, Backs in ... blog containing the Canadian Physical Activity and Sedentary ... for Exercise Physiology (CSEP). Since the CSEP is ... fitness research and personal training in Canada, its ... beneficial and a rich resource for many people. ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2
(Date:5/6/2015)... NEW YORK , May 6, 2015 /PRNewswire/ ... patient activation and patient-reported outcomes for chronic pain, ... report released by The Bravewell Collaborative ... by the Patients Receiving Integrative Medicine Interventions Effectiveness ... medicine. Using data from PRIMIER ...
(Date:5/6/2015)... May 6, 2015 Saint-Gobain has ... manufacture of filtration products, mainly for the life sciences ... filters manufactured in a state-of-the-art plant in ... sold across the globe and will bolster the range ... This acquisition is fully in line with the ...
(Date:5/6/2015)... 2015 Fibich, Leebron, Copeland, Briggs & Josephson ... has been reached to resolve lawsuits involving individuals who ... Actos - manufactured by Takeda Pharmaceuticals - has been ... Several of the firm,s attorneys were instrumental in the ... Tommy Fibich - Founding Partner of Fibich, Leebron, ...
Breaking Medicine Technology:Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2
Cached News: